LONDON, ONTARIO March 10, 2017 — Representatives from OB Pharmaceuticals attended BioEurope Spring 2017 in Barcelona, Spain, March 20-22 to meet with potential pharma and venture partners to expand development of its promising novel molecules for the treatment and prevention of epilepsy and other related seizure disorders.
About BioEurope Spring
With a focus on European innovation and global collaboration, BIO-Europe Spring is the premier springtime partnering conference from biotech, pharma and finance in the most innovative biopharma clusters in Europe. BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.
About OB Pharmaceuticals
OB Pharmaceuticals is an early stage biopharmaceutical company dedicated to improving the lives of individuals through the development of first-in-class therapeutics for more effective prevention and management of epilepsy and other related seizure disorders.